Dr Eric S Sztejman, MD in Marlton, NJ - Medicare Critical Care (intensivists)

Dr Eric S Sztejman, MD is a medicare enrolled "Internal Medicine - Critical Care Medicine" physician in Marlton, New Jersey. He graduated from medical school in 2000 and has 24 years of diverse experience with area of expertise as Critical Care (intensivists). He is a member of the group practice Virtua Medical Group, Pa and his current practice location is 141 Route 70 E Ste B, Marlton, New Jersey. You can reach out to his office (for appointments etc.) via phone at (856) 596-9057.

Dr Eric S Sztejman is licensed to practice in New Jersey (license number 25MA08044400) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1255386355.

Contact Information

	Dr Eric S Sztejman, MD
	141 Route 70 E Ste B, Marlton, NJ 08053-1855
	(856) 596-9057
	(856) 596-0837

Physician's Profile

Full Name	Dr Eric S Sztejman
Gender	Male
Speciality	Critical Care (intensivists)
Experience	24 Years
Location	141 Route 70 E Ste B, Marlton, New Jersey
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Eric S Sztejman graduated from medical school in 2000

NPI Data:

NPI Number: 1255386355
Provider Enumeration Date: 05/24/2006
Last Update Date: 04/15/2022

Medicare PECOS Information:

PECOS PAC ID: 6305819558
Enrollment ID: I20070116000303

Medical Identifiers

Medical identifiers for Dr Eric S Sztejman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1255386355	NPI	-	NPPES
0133256	Medicaid	NJ

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RP1001X	Internal Medicine - Pulmonary Disease	25MA08044400 (New Jersey)	Secondary
207RC0200X	Internal Medicine - Critical Care Medicine	25MA08044400 (New Jersey)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Virtua West Jersey Hospitals	Voorhees, NJ	Hospital
Virtua Our Lady Of Lourdes Hospital	Camden, NJ	Hospital
Virtua Memorial Hospital Of Burlington County	Mount holly, NJ	Hospital
Virtua Willingboro Hospital	Willingboro, NJ	Hospital
Penn Presbyterian Medical Center	Philadelphia, PA	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Virtua Medical Group, Pa	9830222397	1226

News Archive

Neem Biotech to share findings on cystic fibrosis biofilm disruption at ECFS Basic Science Conference

Neem Biotech, a Wales-based R&D biotech working in the field of novel antimicrobial drug development, announced today that it will be presenting results of its ongoing development work into the impact of NX-AS-401, its lead candidate,on biofilms in chronic cystic fibrosis lung infections at the 15th European Cystic Fibrosis Basic Science Conference taking place from 21st to 24th March 2018 in LoutrakiKorinthias, Greece.

Bohai second quarter net revenues increase 32% to $22.2 million

Bohai Pharmaceuticals Group, Inc., a China-based pharmaceutical company engaged in the production, manufacturing and distribution of Traditional Chinese Medicine (TCM) in China, today reported record financial results for its second quarter of fiscal 2011 ended December 31, 2010.

BEST files initial public offering of common stock

Bruker Corporation,a leading global provider of high-performance scientific instruments, and Bruker Energy & Supercon Technologies, Inc. ("BEST"), a leading provider of superconducting technology and enabling tools and a Bruker subsidiary, today announced that BEST has filed a Form S-1 Registration Statement with the United States Securities and Exchange Commission relating to the proposed initial public offering (the "offering") of common stock of BEST.

Lung cancer screening rates remain very low and unchanged among smokers, study finds

Lung cancer screening rates remained very low and unchanged among eligible populations in 2015, despite recommendations that high risk current and former smokers be screened.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Eric S Sztejman allows following entities to bill medicare on his behalf.

Entity Name	Virtua Medical Group, Pa
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338

News Archive

Neem Biotech to share findings on cystic fibrosis biofilm disruption at ECFS Basic Science Conference

Bohai second quarter net revenues increase 32% to $22.2 million

BEST files initial public offering of common stock

Lung cancer screening rates remain very low and unchanged among smokers, study finds

Lung cancer screening rates remained very low and unchanged among eligible populations in 2015, despite recommendations that high risk current and former smokers be screened.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Eric S Sztejman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Eric S Sztejman, MD 301 Lippincott Dr Ste 410, Marlton, NJ 08053-4197 Ph: (856) 355-0340	Dr Eric S Sztejman, MD 141 Route 70 E Ste B, Marlton, NJ 08053-1855 Ph: (856) 596-9057

News Archive

Neem Biotech to share findings on cystic fibrosis biofilm disruption at ECFS Basic Science Conference

Bohai second quarter net revenues increase 32% to $22.2 million

BEST files initial public offering of common stock

Lung cancer screening rates remain very low and unchanged among smokers, study finds

Lung cancer screening rates remained very low and unchanged among eligible populations in 2015, despite recommendations that high risk current and former smokers be screened.

Internal Medicine Doctors in Marlton, NJ

Dr. Mahbubur Siddique, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 90 Brick Rd Fl 3, Marlton, NJ 08053 Phone: 856-355-6000 Fax: 856-355-6731
Rina De Guzman Zuniga, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 141 Route 70 E Ste E, Marlton, NJ 08053 Phone: 856-985-7373 Fax: 856-985-9611
Dr. Abraham S. Horn, D.O. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 406 Lippincott Drive, Suite E, Marlton, NJ 08053 Phone: 856-983-1900 Fax: 856-983-1914
Martin Karl Belsky, D.O. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Brick Rd, Suite # 108, Marlton, NJ 08053 Phone: 856-810-7337 Fax: 856-810-7917
James Nicholas Kimbaris, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 Route 73 N Ste 101, Marlton, NJ 08053 Phone: 856-237-8045 Fax: 856-237-8047
Dr. Gerald M Braverman, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 306 Posterity Pl, Marlton, NJ 08053 Phone: 856-988-0114
Stacey Rene Zavala, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 406 Lippincott Dr Ste E, Marlton, NJ 08053 Phone: 856-983-1900 Fax: 856-983-5110

Dr Eric S Sztejman, MD - Medicare Critical Care (intensivists) in Marlton, NJ

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Neem Biotech to share findings on cystic fibrosis biofilm disruption at ECFS Basic Science Conference

Bohai second quarter net revenues increase 32% to $22.2 million

BEST files initial public offering of common stock

Lung cancer screening rates remain very low and unchanged among smokers, study finds

Medicare Reassignments

Neem Biotech to share findings on cystic fibrosis biofilm disruption at ECFS Basic Science Conference

Bohai second quarter net revenues increase 32% to $22.2 million

BEST files initial public offering of common stock

Lung cancer screening rates remain very low and unchanged among smokers, study finds

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Neem Biotech to share findings on cystic fibrosis biofilm disruption at ECFS Basic Science Conference

Bohai second quarter net revenues increase 32% to $22.2 million

BEST files initial public offering of common stock

Lung cancer screening rates remain very low and unchanged among smokers, study finds

Internal Medicine Doctors in Marlton, NJ